“Baseline Characteristics in Patients With Atopic Dermatitis from the North American Prospective Observational Study of Lebrikizumab (ADjoy)”. SKIN The Journal of Cutaneous Medicine, vol. 10, no. 2, Mar. 2026, p. s734, https://doi.org/10.25251/djee0862.